In thyroid carcinoma, BRAFV600E tumours show increased expression of glucose transporter (GLUT) and higher SUVs compared to BRAFV600 wild-type tumours [26, 27]. The gene discussed is SLC2A1; the disease is thyroid gland carcinoma.